Last reviewed · How we verify
DEN vaccine F17
DEN vaccine F17 is a Biologic drug developed by U.S. Army Medical Research and Development Command. It is currently in Phase 1 development. Also known as: Live attenuated tetravalent dengue (DEN) vaccine.
At a glance
| Generic name | DEN vaccine F17 |
|---|---|
| Also known as | Live attenuated tetravalent dengue (DEN) vaccine |
| Sponsor | U.S. Army Medical Research and Development Command |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults (PHASE2)
- A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children (PHASE1, PHASE2)
- A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants (PHASE1, PHASE2)
- A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children (PHASE2)
- A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand (PHASE2)
- A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DEN vaccine F17 CI brief — competitive landscape report
- DEN vaccine F17 updates RSS · CI watch RSS
- U.S. Army Medical Research and Development Command portfolio CI
Frequently asked questions about DEN vaccine F17
What is DEN vaccine F17?
DEN vaccine F17 is a Biologic drug developed by U.S. Army Medical Research and Development Command.
Who makes DEN vaccine F17?
DEN vaccine F17 is developed by U.S. Army Medical Research and Development Command (see full U.S. Army Medical Research and Development Command pipeline at /company/u-s-army-medical-research-and-development-command).
Is DEN vaccine F17 also known as anything else?
DEN vaccine F17 is also known as Live attenuated tetravalent dengue (DEN) vaccine.
What development phase is DEN vaccine F17 in?
DEN vaccine F17 is in Phase 1.
Related
- Manufacturer: U.S. Army Medical Research and Development Command — full pipeline
- Also known as: Live attenuated tetravalent dengue (DEN) vaccine
- Compare: DEN vaccine F17 vs similar drugs
- Pricing: DEN vaccine F17 cost, discount & access